SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-20-112420
Filing Date
2020-10-06
Accepted
2020-10-06 07:51:51
Documents
14
Period of Report
2020-10-05
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2032563-1_8k.htm   iXBRL 8-K 25811
2 EXHIBIT 99.1 tm2032563d1_ex99-1.htm EX-99.1 12479
6 GRAPHIC tm2032563d1_ex99-1img01.jpg GRAPHIC 4330
  Complete submission text file 0001104659-20-112420.txt   224473

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA ymab-20201005.xsd EX-101.SCH 3177
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE ymab-20201005_lab.xml EX-101.LAB 34591
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE ymab-20201005_pre.xml EX-101.PRE 22704
7 EXTRACTED XBRL INSTANCE DOCUMENT tm2032563-1_8k_htm.xml XML 3709
Mailing Address 750 THIRD AVENUE 9TH FLOOR NEW YORK NY 10017
Business Address 750 THIRD AVENUE 9TH FLOOR NEW YORK NY 10017 212-847-9841
Y-mAbs Therapeutics, Inc. (Filer) CIK: 0001722964 (see all company filings)

IRS No.: 474619612 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38650 | Film No.: 201225589
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences